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Summary.-There is now evidence that several classes of nitro compounds which
have been used as radiosensitizers also function as cytotoxic agents specific for
hypoxic cells. The 2-nitroimidazole, Ro-07-0582, (1-(2-nitroimidazol-1-yl)-3-
methoxy-2-propanol) is a compound of this type, and its effectiveness as a cytotoxic
agent is dependent on drug concentration, contact time and temperature. In vitro,
Ro-07-0582 in air at 37°C does not cause loss of cell viability at concentrations up to
2 mM, even when in contact for several days. In contrast, hypoxic cells do not
tolerate much lower concentrations of drug, even if the contact time is only a few
hours. When the temperature is raised above 37°C, there is a pronounced increase
in the slope of the survival curves; for example, at 41°C (for 1 mM Ro-07-0582, (200
,ug/ml), the slope changes by a factor of2-0 relative to that for 37°C. For cells in air
at 41°C, as at 37°C, there is no toxic effect at the concentration of drug tested. In the
absence of drug, there is no cytotoxic effect of hyperthermia alone under these con-
ditions. These results are discussed in terms of Arrhenius parameters.
THE relative radioresistance ofhypoxic
cells believed to be present in some human
tumours is a likely cause oflocal failure in
radiotherapy. Methodssuggestedtoover-
come the problem include the use of
hypoxic cellradiosensitizers(Adams, 1973),
agents which selectively increase the
radiosensitivity of hypoxic cells without
affecting the radiosensitivity of well-
oxygenated cells in normal tissue. The
rationale of this approach is that, unlike
02, some chemical sensitizers are not
rapidly metabolized and are able, there-
fore, to diffuse from the capillaries to the
distant hypoxic cells in the tumour.
There are many compounds of widely
different chemical structure known to be
very efficient radiosensitizers in vitro,
although most of these have little or no
effect in vivo, due mainly to their meta-
bolic instability. At the present time,
the most promising compounds are the
nitroimidazoles, 2 of which, metroni-
dazole, a 5-nitroimidazole (Flagylg; May &
Baker Ltd), and Ro-07-0582, a 2-nitro-
imidazole (Roche Products Ltd) have
been investigated extensively, both in
vitro and in vivo (for extensive review see
Proceedings of review panel "Modifi-
cation of Radiosensitivity of Biological
systems" IAEA, Vienna 1976). Results
of preliminary clinical investigations with
these drugs have been published (Urtasun
etal., 1975, 1976; Gray et al., 1976; Dische,
Gray and Zanelli, 1976; Thomlinson et al.,
1976).
An interesting recent finding is that
both these drugs display a marked
differential cytotoxicity towards hypoxic
relative to well-oxygenated cells (Suther-
land, 1974; Hall and Roizin-Towle, 1975;
Foster et al., 1976; Mohindra and Rauth,
1976), and this has led to consideration of
their possible future role in cancer chemo-
therapy in addition to their use as radio-
sensitizers. During investigations into
the mechanism of this effect, we have
found that moderate hyperthermia pro-I. J. STRATFORD AND G. E. ADAMS
duces a marked increase in the differential
cytotoxicity of Ro-07-0582 towards hypo-
xic mammalian cells. This paper de-
scribes the effect of temperature in the
range 25° to 41°C on the cytotoxic effect
ofRo-07-0582 on hypoxic Chinese hamster
V79 cells in vitro.
MATERIALS AND METHODS
Chinese hamster cells of the V79-379A
line were grown at 37°C in 250 ml glass
spinner flasks in Eagle's Minimal Essential
Medium (MEM) modified for suspension
cultures (Flow Laboratories Ltd) and supple-
mented with 7.5% foetal calf serum (FCS,
Gibco Bio-Cult Ltd). The cells were main-
tained in log phase at concentrations ranging
between 105 and 106 cells per ml; dilutions
were made daily.
Toxicity experiments were carried out in
spinner flasks fitted with a gas inlet/outlet
system and a sidearm through which samples
couldbewithdrawn. Flaskscontainingabout
100 ml of a suspension containing asyn-
chronous log-phase cells at a concentration
of about 5 x 105 cells/ml were placed in a
water bath at 37°C. Drug was then added
and samples of cells withdrawn at appro-
priate intervals after the initial inoculation.
Cells were washed free of drug by centri-
fugation and resuspension, counted, serially
diluted, plated in MEM plus 15% FCS and
incubated at 37°C in 95% air plus 5% CO2-
Survival was taken as the ability of a single
cell to form a visible colony 7 to 10 days after
plating. Surviving fractions were calculated
andexpressed as afunctionofthe contact time
with drug at a particular temperature.
For anaerobic toxicity experiments, cells
were first de-aerated by flowing 95% N2/
5% CO2 (BOC, < 10 ppm 02) at a rate of
500 ml/min over the surface of the stirred
suspension for at least 1 h at 37°C, or lower
temperature where appropriate; the 02 con-
centration in the effluent gas was steady at
< 10 ppm 02 after this time. After de-
aeration, a de-aerated solution of Ro-07-0582
was added to the cell suspension via the
stoppered port. Forthe hyperthermia range,
the temperature of the water bath was then
increased from 37°C, and 10 min was allowed
for thermal equilibrium. The flow of N2
over the stirred suspension was continued
throughout the experiment.
RESULTS AND DISCUSSION
(a) Effect of Ro-07-0582 on cell viability at
37°C
Aerobic cells were exposed to various
concentrations of drug at 37°C and Fig. 1
shows growth curves for cells held in 1, 2
and 5 mm Ro-07-0582. In the absence of
drug, the average cell doubling time is
12-13 h. With Ro-07-0582 present, the
cells undergo division, although the rate
decreases as the concentration of drug
increases. At 5 mm, division effectively
ceases.
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FIG. 1. Growth of V79-379A cells in suspen-
sion culture in air in the presence of various
concentrations of Ro-07-0582 at 37°C.
These results for aerobic cells contrast
markedly with those for hypoxic cells
maintained in contact with Ro-07-0582.
Fig. 2 shows plots of surviving fraction
against time in hours for hypoxic sus-
pensions containing 0 5, 1P0 and 2 0 mM
Ro-07-0582. In the drug-free control,
there is no loss of viability during the
course of the experiments. With drug
present, there is an initial shoulder, after
which cell survival decreases exponen-
tially with time. The rate ofthe decrease
is dependent upon the concentration of
Ro-07-0582 in the medium. Over these
contact times, similar concentrations of
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FIG. 2.-Survival of cells exposed to various
concentrations of Ro-07-0582 for various
times under hypoxic conditions at 37°C.
x no drug, 0 O05 mM, A 1 mM,
*-2 mM.
Ro-07-0582 do not affect the viability of
aerobic cells. These results are in agree-
ment with previous observations on the
differential hypoxic cell-toxicity of both
Ro-07-0582 and metronidazole (Suther-
land, 1974; Hall and Roizin-Towle, 1975;
Foster et al., 1976; Mohindra and Rauth,
1976).
(b) The effect of temperature on hypoxic cell
toxicity
Fig. 3 shows cell survival data for
hypoxic cells maintained in contact with
various concentrations of Ro-07-0582 at
250, 310, 390 and 41°C. For all the
temperatures tested, up to and including
410C, the viability of hypoxic cells is
unaffected in the absence of drug. How-
ever, the hypoxic cell toxicity of Ro-07-
0582 clearly increases with temperature
over this range. Control experiments
carried out in air for each temperature
showed that these concentrations of Ro-
07-0582 did not affect the viability of
aerobic cells, even after several days'
contact. In fact, cells in 2 mM Ro-07-
0582 at 41°C undergo several divisions in
this time.
The dashed lines in Fig. 3D are the
survival data for 37°C, transposed from
Fig. 2 for comparison. The arrows in the
figure indicate the considerable increase
in cytotoxicity caused by a rise in tem-
perature of only 40C for the three Ro-07-
0582 concentrations indicated. Generally
as the temperature is increased, the rate of
cell killing, as measured by the slope ofthe
exponential portion ofthe survival curves,
increases. Also, the increase in tempera-
ture, certainly at concentrations of 2 mm
Ro-07-0582 and above, greatly reduces the
shoulder on the survival curves.
The hypoxic celltoxicity ofRo-07-0582
is clearly dependent upon temperature,
drug concentration and overall contact
time. This is illustrated by the iso-
effect curves shown in Fig. 4. The data
indicate the contact time required for
reduction of cell survival by a factor of
10-3, plotted as a function of Ro-07-0582
concentration for the 4 different tempera-
tures. As the temperature increases, the
concentrations of drug and the contact
time necessary to reach a given level of
survival both decrease.
(c) Analysis of temperature dependence in
terms of Arrhenius parameters
It is assumed that the toxicity is due
to the reaction either of the sensitizer, or
of some metabolic breakdown product of
the senitizer, with criticaltarget molecules,
or sites within the cell. If this reaction
leads directly to loss of cell viability, then
it should be possible to derive the acti-
vation energy for the reaction.
Let the effective concentration of
critical targets at time t after contact
with the sensitizer be x, and let S be the
initial concentration of the sensitizer.
Then
dt k [S] [x]
where k is a reaction constant.
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FIG. 3. Survival of cells exposed to various concentrations of Ro-07-0582 for various times under
hypoxic conditions at a range of temperatures. A, (25°C) and B, (31°C): x -no drug, 0 5 mM,
A-10 mM, * 20 mm. C, (39°C) and D, (41°C): x no drug, 0 0 5 mm, A-] mM, *-2 mM.
Dashed lines are the data from Fig. 2, (37°C) transposed for comparison.
Since the concentration of S available
in the medium is unchanged throughout
the inactivation
dx
[x]
k [S] dt
whence
In x k[S]t + constant.
When
[x] [xo] (initial), t 0
In[XI -k[S]t (1)
If the fraction of cells surviving (f) is
proportional to the fraction ofundamaged
critical sites in the cell
then
f B [X]
[xw]
where B is a constant
from (1)
In f= k[S]t
By the Arrhenius equation
Ink= - E
RT
where E - activation energy
T absolute temperature
R gas constant
C -- constant
(2)
(3)
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FIG. 4.-The concentration of Ro-07-0582 as
a function ofthe time required for reduction
of cell surviving fraction to 10-3 at a range
of temperatures under hypoxic conditions.
refer to reduction of survival by a factor
of 10-3 and a contact time of 5 h. Values
of S' were read off from curves similar to
those shown in Fig. 4 for 7 different
temperatures ranging from 250 to 41TC.
These values are plotted logarithmically as
a function of 1/T in Fig. 5.
It is quite evident that, over this
temperature range, equation 5 is not
obeyed. However, the data are con-
sistent with a line showing a well-defined
breakpoint corresponding to a tempera-
ture of , 360. On the basis that the
plot consists of 2 linear portions, the
corresDondina activation eneraies (E) for Z^_ssst
VV s-1 Ist \-&a L" 1
the reactions causing the toxic response as
s derived from the slopes, are E = 107
kJ/mol (26 kcal/mol) for T < 36°C and
I E = 206 kJ/mol (49 kcal/mol) for T
> 360C.
From (2) for a fixed contact time and a
given level of survival,
k- S K (4)
where
K ln- Bt
and S' is the concentration of sensitizer
required for the appropriate surviving
fraction and contact time.
Therefore from (3)
K
ln ]1
-E/RT + C
or
E
ln [S'] RT +ln K + C (5)
Hence, a plot of ln[S'] should be linear
with 1/T with slope E/R. The quantity
S' we designate the " specific cyto-
toxicity ", i.e. the concentration required
to produce a given cytotoxic effect after a
fixed contact time. For the purpose of
testing the applicability of equation (5),
values of S' for different temperatures
22
(d) Nature of the toxic specie8
If the toxicity were due simply to the
reaction of Ro-07-0582 itself with a
critical target site within the cell, one
might expect that the temperature co-
efficient for the reaction would be con-
stant, both in the hypo- and hyperthermia
range. The breakpoint in Fig. 5 is
suggestive, therefore, that the toxicity is a
consequence of the cellular metabolismn of
Ro-07-0582, and that in the hyperthermia
range the increased metabolism is respon-
sible for that enhanced temperature co-
efficient. Spectrophotometric analysis of
aqueous solutions of Ro-07-0582 shows
that the stability ofthis drug is unaffected
by maintaining the temperature at 41°C
for up to 8 h.
Differential hypoxic cell toxicity is
evident for numerous other nitro-hetero-
cyclic and nitrobenzenoid drugs (Strat-
ford, WattsandAdams, unpub.). Further,
these compounds become more toxic to
hypoxic cells as the electron affinity
increases (Adams et al., unpub.), although
the molecular mechanism of the effect
remains unclear.
It has been proposed that the cyto-
toxic action of some nitro compounds,
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FIG. 5.-Test of applicability of equation 5. Concentration of Ro-07-0582 required to reduce the
surviving fraction of cells to 10-3 after 5 h under hypoxic conditions, as a function of the reciprocal
absolute temperature. The dashed lines are continuations ofthe two linearportions oftheArrhenius
plot.
including nitroimidazoles, against anaero-
bic bacteria is due to the formation of
toxic products by reduction of the NO2
group (McCalla, Reuvers and Kaiser,
1970; Ings,. McFadzean and Ormerod,
1974). For Ro-07-0582, a reduced pro-
duct, believed to be the corresponding
amine, has been identified following incu-
bation of hypoxic cultures of CHO cells
with the drug (Varghese, Gulyas and
Mohindra, 1976).
In order to investigate whether the
amine or other stable reduced products
are responsible for the temperature-sensi-
tive hypoxic cell toxicity, we carried out
the following experiments at 37°C and
41'C. Hypoxic V79 cells were incubated
with 2 mm Ro-07-0582 for a period suf-
ficient to reduce survival to 10-2. 02
was then admitted for 2 h and the cells
then deoxygenated and allowed to remain
in contact with Ro-07-0582 for a further
period. At both temperatures it was
found that the cells were resistant to
further cell killing in hypoxia for a period
approximately equivalent to the initial
shoulder region of the original survival
curve. One possible explanation of this
temporary arrest in toxicity is that
damage responsible for the overall cyto-
toxicity is repaired during the period of
oxygenation. Experiments are in pro-
gress designed to investigate this possi-
bility.
It is difficult to interpret the above
result on thebasis that cell killing is due to
the accumulation of the amine of Ro-07-
0582 during exposure of hypoxic cells to
Ro-07-0582. This amine is stable in 02
over the time course ofthese experiments,
and therefore, if it is produced during the
first period of incubation of hypoxic cells
with Ro-07-0582, its concentration would
not be affected during the period of
oxygenation. Subsequent removal of the
02 should have resulted in an immediate
continuation of the exponential portion
of the survival curve. These preliminary
results suggest that the amine derivative
of Ro-07-0582 per se is not important in
causing the reported temperature-sensitive
cytotoxic effects. However, the possi-
bility that the cytotoxicity is due to
short-lived, unstable intermediates formed
during anaerobic metabolism of Ro-07-
0582 cannot be precluded.
I I I I ,,I I I
,I . I II II II II I
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CONCLUSION
In principle, drugs specifically toxic
towards hypoxic cells could have potential
value as cancer chemotherapy agents,
particularly when used in combination
with agents which are specific for cycling
cells. With respect to Ro-07-0582, serum
levels at least as large as 05 mm can be
achieved in man with an apparent half-
life of about 12 h (Gray et al., 1976). It
would be inferred from the in vitro data at
370C, that tumours in contact with drug
concentrations of this order for several
hours would undergo an appreciable
reduction in hypoxic cell content. Fur-
ther, it would follow that, if the tumour
temperature could be increased by 4C0
over a period ofsome hours, the number of
hypoxic cells could be even further
reduced by the increased cytotoxic action
ofRo-07-0582.
Studies on the combined effect of
hyperthermia and Ro-07-0582 on mouse
tumours (Bleehen, Honess and Morgan,
1977; George, Hirst and McNally, 1977),
have demonstrated that thermal enhance-
ment of the cytotoxic action of this
nitroimidazole does occur in vivo.
Cytotoxic drugs ofthis type may have
a role to play in cancer chemotherapy
generally, in addition to their more
specific use as hypoxic cellradiosensitizers.
If so, the present results indicate that the
efficiency ofcombinations ofradiation and
chemotherapy using Ro-07-0582 or related
drugs may be significantly increased by
the additional use ofmodest hyperthermia.
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